scholarly article | Q13442814 |
P50 | author | Stéphane Potvin | Q34567371 |
Luc Nicole | Q55722389 | ||
Emmanuel Stip | Q60510270 | ||
Alain Lesage | Q60603258 | ||
P2093 | author name string | Olivier Lipp | |
Roch-Hugo Bouchard | |||
Pierre Lalonde | |||
Antoinette Prouteau | |||
Catherine Briand | |||
P433 | issue | 1 | |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 38-42 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Brain and Cognition | Q4955810 |
P1476 | title | CANTAB explicit memory is less impaired in addicted schizophrenia patients. | |
P478 | volume | 59 |
Q34530176 | BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA. |
Q51969760 | Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. |
Q50993509 | Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. |
Q37643444 | Cannabis use and cognition in schizophrenia |
Q47945952 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls |
Q38401669 | Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia |
Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
Q47739996 | Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls |
Q37340922 | Effects of early psychosocial deprivation on the development of memory and executive function |
Q44346792 | Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication. |
Q36577094 | Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis. |
Q58597807 | Inhibition, shifting and updating in relation to psychometric intelligence across ability groups in the psychiatric population |
Q43872699 | Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. |
Q36959030 | Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study |
Q33762494 | Neurocognitive functioning of individuals with schizophrenia: using and not using drugs |
Q39577163 | Predictors of community functioning in schizophrenia and substance use disorder patients |
Q35091697 | Subjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link? |
Q36591245 | Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia |
Q34531537 | The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability |
Q33641039 | The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample |
Q37061404 | The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study |
Q36965847 | The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues |
Q36370752 | Visual memory of meaningless shapes in children and adolescents with autism spectrum disorders |
Q51952571 | Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. |
Search more.